A cognitive-perceptual approach to conceptualizing speech intelligibility deficits and remediation practice in Hypokinetic dysarthria

    A perfusion MRI study of emotional valence and arousal in Parkinson's disease

    A preliminary report on disordered speech with deep brain stimulation in individuals with Parkinson's disease

    A review of social and relational aspects of deep brain stimulation in parkinson's disease informed by healthcare provider experiences

    Abnormalities of the first three steps of gait initiation in patients with Parkinson's disease with freezing of gait

    Acoustic analysis of PD speech

    Adolescent and adult children of parents with Parkinson's disease: Incorporating their needs in clinical guidelines

    Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders

    Animal models of parkinson's disease

    Assessment of prosodic communicative efficiency in Parkinson's disease as judged by professional listeners

    Bladder,bowel,and sexual dysfunction in Parkinson's disease

    Communication impairments in parkinson's disease

    Contribution of alanine-76 and serine phosphorylation in α-synuclein membrane association and aggregation in yeasts

    Critical aspects of clinical trial design for novel cell and gene therapies

    Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: Effects on diadochokinetic rate

    Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: Effects on voice intensity

    Dementia after DBS surgery: A case report and literature review

    Development of a non-motor fluctuation assessment instrument for Parkinson disease

    Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: Implications for cognitive function

    Diversity in the regulation of autophagy and mitophagy: Lessons from Parkinson's disease

    Do PPAR-gamma agonists have a future in parkinson's disease therapy?

    Do somatic mitochondrial dna mutations contribute to parkinson's disease?

    Dopamine-induced nonmotor symptoms of parkinson's disease

    Drosophila models of Parkinson's disease: Discovering relevant pathways and novel therapeutic strategies

    Effect of LSVT on lexical tone in speakers with Parkinson's disease

    Effect of deep brain stimulation on parkinson's nonmotor symptoms following unilateral DBS: A pilot study

    Effects of human alpha-synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease

    Genetic mutations and mitochondrial toxins shed new light on the pathogenesis of Parkinson's disease

    High-level language production in Parkinson's disease: A review

    Idiopathic REM sleep behavior disorder: Implications for the pathogenesis of lewy body diseases

    Imaging impulsivity in Parkinson's disease and the contribution of the subthalamic nucleus

    Impact of external cue validity on driving performance in Parkinson's disease

    Impulse control disorders following deep brain stimulation of the subthalamic nucleus in parkinson's disease: Clinical aspects

    Inflammation and parkinson's disease

    Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease

    Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease

    Limitations of animal models of Parkinson's disease

    Lingual kinematics in dysarthric and nondysarthric speakers with Parkinson's disease

    Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease

    Lipopolysaccharide animal models for parkinson's disease

    MPTP neurotoxicity and testosterone induce dendritic remodeling of striatal medium spiny neurons in the C57Bl/6 mouse

    Manganese inhalation as a Parkinson disease model

    Manganese-induced parkinsonism due to ephedrone abuse

    Medication responsiveness of motor symptoms in a population-based study of parkinson disease

    Mitochondria and Parkinson's disease

    Mitochondrial contribution to parkinson's disease pathogenesis

    Mitochondrial dysfunction in Parkinson's disease

    Mitochondrial dysfunction in Parkinson's disease: Pathogenesis and neuroprotection

    Mitochondrial dysfunction: The road to alpha-synuclein oligomerization in PD

    Mitochondrial fusion/fission,transport and autophagy in Parkinson's disease: When mitochondria get nasty

    Models for LRRK2-linked parkinsonism

    Neurobiology of depression and anxiety in parkinson's disease

    Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease

    New thoughts on thought disorders in Parkinson's disease: Review of current research strategies and challenges

    Nondipping in Parkinson's disease

    Nonmotor symptoms groups in Parkinson's disease patients: Results of a pilot,exploratory study

    Nonmotor symptoms in patients with PARK2 mutations

    Nonmotor symptoms of Parkinson's disease

    Olfactory loss in parkinson's disease

    Optimizing a rodent model of parkinson's disease for exploring the effects and mechanisms of deep brain stimulation

    PINK1-interacting proteins: Proteomic analysis of overexpressed PINK1

    Parkinson's disease and systemic inflammation

    Perceived changes in communication as an effect of STN surgery in Parkinson's disease: A qualitative interview study

    Perception of speech by individuals with Parkinson's disease: A review

    Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: Possible implication in parkinson's disease incidence

    Phytic acid protects against 6-hydroxydopamine-induced dopaminergic neuron apoptosis in normal and iron excess conditions in a cell culture model

    Protective role of rAAV-NDI1,serotype 5,in an acute MPTP mouse Parkinson's model

    Relation of subjective quality of life to motor symptom profile in Parkinson's disease

    Sentence comprehension and its association with executive functions in patients with Parkinson's disease

    Serum adiponectin levels in advanced-stage Parkinson's disease patients

    Sleep disturbances associated with Parkinson's disease

    Sleep duration and on time during different periods of the day and night in patients with advanced parkinson's disease receiving adjunctive ropinirole prolonged release

    The Nrf2/ARE pathway: A promising target to counteract mitochondrial dysfunction in Parkinson's disease

    The degenerating substantia Nigra as a susceptible region for gene transfer-mediated inflammation

    The endotoxin-induced neuroinflammation model of Parkinson's disease

    The frequency of nonmotor symptoms among advanced Parkinson patients may depend on instrument used for assessment

    The influence of dopamine on automatic and controlled semantic activation in Parkinson's disease

    The involvement of neuroinflammation and Kynurenine pathway in Parkinson's disease

    The on-freezing phenomenon: Cognitive and behavioral aspects

    The possible clinical predictors of fatigue in parkinson's disease: A study of 135 patients as part of international nonmotor scale validation project

    The role of cognitive-behavioural therapy for patients with depression in Parkinson's disease

    Therapeutic effects of hydrogen in animal models of Parkinson's disease

    Toxin-induced and genetic animal models of Parkinson's disease

    Traditional chinese medicine improves activities of daily living in parkinson's disease

    Transcriptional factor NF-κb as a target for therapy in Parkinson's disease

    VMAT2-deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of Parkinson's disease

    Visual symptoms in Parkinson's disease

    α-Synuclein transgenic Drosophila as a model of Parkinson's disease and related synucleinopathies